| Tender Title | Inj Rituximab 100mg | ||
| Tender ID | NA | Tender Reference Number | H4261147A |
| Tender Type | Open/advertised | ||
| Tender Opening Date | 2026-02-16 09:19 AM | Tender Closing Date | 2026-03-10 09:00 AM |
| Tender Value | Refer Document | Tender Location | Mumbai Cst , Thane , Maharashtra |
| Tender Category | Goods | Product Category | Healthcare and Medicine Tenders |
| ePublished Date | 2026-02-16 09:19 AM | Bid Opening Date | 2026-03-10 09:00 AM |
| Document Download Start Date | 2026-02-16 09:19 AM | Document Download End Date | 2026-03-10 09:00 AM |
| Bid Submission Start Date | 2026-02-16 09:19 AM | Bid Submission End Date | 2026-03-10 09:00 AM |
| Clarification start Date | Clarification End Date | ||
| Bid Validity Period (in Days) | NA |
| Tender Fee | Refer document |
| EMD (Earnest Money Deposit) | Refer document |
| EMD Fee Type | NA |
| Payment Instruments/Mode | NA |
Work Description - For Complete Deion And Other Details, Please Refer To Tender
The Ministry of Railways, a Central Government Ministry/Department, invites open tenders for the supply of INJ RITUXIMAB 100MG (Tender Reference Number H4261147A) for delivery at Mumbai CST. This tender falls under the 'Goods' category and specifically targets 'Railway related Products.' The tender document, containing the complete work description and other pertinent details, can be downloaded from 16-Feb-2026 02:49 PM until 10-Mar-2026 02:30 PM. Bids must be submitted electronically between 16-Feb-2026 02:49 PM and 10-Mar-2026 02:30 PM. The bid opening date is scheduled for 10-Mar-2026 02:30 PM. No Tender Fee or Earnest Money Deposit (EMD) is required. Inquiries regarding this tender should be directed to CMS/KYN-MEDICAL/CENTRAL RLY, Div Hospital Kalyan. Prospective bidders are strongly encouraged to carefully review the complete tender document.

Get Hassle free financing for your business
| Office Inviting Bids | Cms/kyn-medical/central Rly |
| Address | Div Hospital Kalyan |
| Contact Details | NA |
| NA | |
| Website | NA |
Hydrocortisone Sodium Succinate 100mg Inj..read more
Ami No.16.63-2026-27 Inj. Panitumumab 100mg..read more
Ami No.16.52/2026-27 Inj Nivolumab 100mg Ami No.16.53/2026-27 Inj Nivolumab 40mg..read more
Ami No.16.74/2026-27 Tdm-1 (ado-trastuzumab Emtansine) Inj 100mg..read more
Inj. Natural Surfactant (phospholipid 80-100mg/ml With Surfactant Associated Protein) 1.5ml..read more
All the major brands in each raw material category